ATE244299T1 - Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis - Google Patents
Test und behandlung von demyelinierenden krankheiten wie multiple sklerosisInfo
- Publication number
- ATE244299T1 ATE244299T1 AT94904474T AT94904474T ATE244299T1 AT E244299 T1 ATE244299 T1 AT E244299T1 AT 94904474 T AT94904474 T AT 94904474T AT 94904474 T AT94904474 T AT 94904474T AT E244299 T1 ATE244299 T1 AT E244299T1
- Authority
- AT
- Austria
- Prior art keywords
- multiple sclerosis
- testing
- demyelinating diseases
- relates
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/829—Blood
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/837—Lymph; lymph-glands; thymus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/838—Marrow; spleen
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/839—Nerves; brain
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US99264192A | 1992-12-18 | 1992-12-18 | |
US16617193A | 1993-12-16 | 1993-12-16 | |
PCT/US1993/012296 WO1994014846A1 (en) | 1992-12-18 | 1993-12-17 | Assay and treatment for demyelinating diseases such as multiple sclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE244299T1 true ATE244299T1 (de) | 2003-07-15 |
Family
ID=26862018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94904474T ATE244299T1 (de) | 1992-12-18 | 1993-12-17 | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis |
Country Status (9)
Country | Link |
---|---|
US (2) | US5645997A (de) |
EP (1) | EP0674661B1 (de) |
AT (1) | ATE244299T1 (de) |
AU (1) | AU689091B2 (de) |
DE (1) | DE69333076T2 (de) |
NZ (1) | NZ259636A (de) |
PL (1) | PL177771B1 (de) |
RU (1) | RU2137131C1 (de) |
WO (1) | WO1994014846A1 (de) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US20070038231A1 (en) | 1999-05-28 | 2007-02-15 | Ferree Bret A | Methods and apparatus for treating disc herniation and preventing the extrusion of interbody bone graft |
PT1272211E (pt) * | 2000-04-07 | 2007-09-14 | Signal Coordinating Therapy In | Métodos e composições papa tratar neoplasmas |
CA2774959C (en) | 2000-08-04 | 2016-05-31 | Dmi Biosciences, Inc. | Method of using diketopiperazines and composition containing them |
CA2451351A1 (en) * | 2001-06-22 | 2003-01-03 | Burkhard Jansen | A method for diagnosing a person having multiple sclerosis |
CA2500652A1 (en) * | 2002-10-02 | 2004-04-15 | Dmi Biosciences, Inc. | Diagnosis and monitoring of diseases |
JP2007500747A (ja) | 2003-05-15 | 2007-01-18 | ディーエムアイ バイオサイエンシズ インコーポレイテッド | T細胞媒介性疾患の処置 |
US20060160151A1 (en) * | 2005-01-10 | 2006-07-20 | Baylor College Of Medicine | Method of quantitative immunohistochemistry and in situ hybridization |
CA2595126A1 (en) * | 2005-01-14 | 2006-07-20 | The Regents Of The University Of California | Methods and compositions for preventing and treating a disease related to glycan dysregulation |
JP5856843B2 (ja) * | 2008-05-27 | 2016-02-10 | アンピオ ファーマシューティカルズ,インコーポレイテッド | ジケトピペラジンを用いた医薬組成物 |
CA2810844C (en) | 2010-09-07 | 2017-03-21 | Dmi Acquisition Corp. | Diketopiperazine compositions for the treatment of metabolic syndrome and related conditions |
SG10201608087WA (en) | 2011-10-10 | 2016-11-29 | Ampio Pharmaceuticals Inc | Implantable medical devices with increased immune tolerance, and methods for making and implanting |
EP2766029B1 (de) | 2011-10-10 | 2020-03-25 | Ampio Pharmaceuticals, Inc. | Behandlung degenerativer gelenkerkrankungen |
MX355446B (es) | 2011-10-28 | 2018-04-18 | Ampio Pharmaceuticals Inc | Tratamiento de rinitis. |
CA2906864A1 (en) | 2013-03-15 | 2014-09-18 | Ampio Pharmaceuticals, Inc. | Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same |
KR20170045274A (ko) | 2014-08-18 | 2017-04-26 | 앰피오 파마슈티컬스 인코퍼레이티드 | 관절 징후의 치료 |
US11389512B2 (en) | 2015-06-22 | 2022-07-19 | Ampio Pharmaceuticals, Inc. | Use of low molecular weight fractions of human serum albumin in treating diseases |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932601A (en) * | 1971-04-07 | 1976-01-13 | Cornell Research Foundation, Inc. | Method and composition for the diagnosis of equine infectious anemia virus infection by using agar-gel-immunodiffusion reaction |
US3929982A (en) * | 1971-11-05 | 1975-12-30 | Cornell Res Foundation Inc | Method and composition for the diagnosis of equine infectous anemia virus infection by using agar-gel-immunodiffusion reaction |
US3864481A (en) * | 1972-12-14 | 1975-02-04 | St Lukes Hospital | Anti disease producing synthetic material for the prevention suppression and diagnosis of multiple sclerosis and method of treatment therefor |
US4113858A (en) * | 1975-01-20 | 1978-09-12 | St. Luke's Hospital | Novel compounds, compositions and methods of their use |
US4294818A (en) * | 1979-07-30 | 1981-10-13 | University Patents, Inc. | Methods and materials for detection of multiple sclerosis |
US4376110A (en) * | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
US4486530A (en) * | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
US4918163A (en) * | 1985-09-27 | 1990-04-17 | Pfizer Inc. | Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria |
AU1765692A (en) * | 1991-03-08 | 1992-10-06 | Uab Research Foundation, The | Novel protein, method and products for detection of oligodendrocytes |
WO1992021367A1 (en) * | 1991-05-31 | 1992-12-10 | Arthur Allen Vandenbark | T cell receptor peptides as therapeutics for immune-related disease |
-
1993
- 1993-12-17 PL PL93309637A patent/PL177771B1/pl not_active IP Right Cessation
- 1993-12-17 RU RU95118411A patent/RU2137131C1/ru not_active IP Right Cessation
- 1993-12-17 AU AU58509/94A patent/AU689091B2/en not_active Ceased
- 1993-12-17 EP EP94904474A patent/EP0674661B1/de not_active Expired - Lifetime
- 1993-12-17 DE DE69333076T patent/DE69333076T2/de not_active Expired - Fee Related
- 1993-12-17 WO PCT/US1993/012296 patent/WO1994014846A1/en active IP Right Grant
- 1993-12-17 NZ NZ259636A patent/NZ259636A/en not_active IP Right Cessation
- 1993-12-17 AT AT94904474T patent/ATE244299T1/de not_active IP Right Cessation
-
1995
- 1995-06-07 US US08/487,066 patent/US5645997A/en not_active Expired - Lifetime
-
1996
- 1996-10-28 US US08/738,259 patent/US5883227A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU5850994A (en) | 1994-07-19 |
DE69333076D1 (de) | 2003-08-07 |
US5883227A (en) | 1999-03-16 |
EP0674661A1 (de) | 1995-10-04 |
AU689091B2 (en) | 1998-03-26 |
EP0674661A4 (de) | 1997-12-10 |
US5645997A (en) | 1997-07-08 |
EP0674661B1 (de) | 2003-07-02 |
DE69333076T2 (de) | 2004-04-15 |
PL309637A1 (en) | 1995-10-30 |
NZ259636A (en) | 1997-10-24 |
WO1994014846A1 (en) | 1994-07-07 |
PL177771B1 (pl) | 2000-01-31 |
RU2137131C1 (ru) | 1999-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE244299T1 (de) | Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis | |
Savage et al. | Antineutrophil cytoplasm antibodies in Kawasaki disease. | |
ATE255902T1 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv- verwandten krankheiten | |
ES2061730T3 (es) | Nuevos anticuerpos. | |
FI941758A (fi) | Rekombitooppipeptidejä | |
DE3780480D1 (de) | Test fuer menschlichen brustkrebs. | |
DE69830588D1 (de) | Diagnose und behandlung von krankheiten mittels anti-t-zell rezeptor-vbeta-antikörper oder peptide, an denen diese antikörper spezifisch binden, und esrp1 | |
DE3879085T2 (de) | Snrnp-a-antigen und fragmente davon. | |
Schneiderman et al. | Activation of the alternative pathway of complement by twelve different rabbit-mouse chimeric transfectoma IgA isotypes. | |
DK0764273T3 (da) | Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose | |
FI922666A0 (fi) | Diagnostiskt foerfarande. | |
WUEPPER et al. | Serologic tests for syphilis and the false-positive reactor | |
DE3688638T2 (de) | Monoklonale Antikörper für humane Lungenkarzinome des "Nicht-kleine-Zellen"-Typs. | |
CA2151945A1 (en) | Assay and treatment for demyelinating diseases such as multiple sclerosis | |
MX9704717A (es) | Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer. | |
Narayan et al. | Fractionation, characterization and diagnostic potential of circulating leprosy antigens isolated from sera of lepromatous leprosy patients | |
Salo et al. | Quantitative Reiter protein complement-fixation test. | |
KR970073606A (ko) | 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정 | |
GB1413800A (en) | Diagnosis of viral diseases | |
DK182188A (da) | Humant tumorassocieret antigen | |
DE69123724T2 (de) | Verfahren zur diagnose von hiv-infektionen | |
PT65676B (fr) | Procede d'isolement et de caracterization de determinees proteines associees aux membranes des celules cancereuses et obtention des correspondants antisoros et anticorps qui permettent etablir un diagnostique et traitement du cancera la base de la detection de ces proteines | |
SU1739559A1 (ru) | Штамм вируса aphtae epizooticae типа o, используемый для изготовления диагностических сывороток и антигенных препаратов |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0674661 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |